研究领域

1.   心血管药物综合诊疗平台—主动性液压心室贴附支持给药系统（ASD）的作用机制研究；

2.   慢性非细菌性前列腺炎（CP/CPPS）的发病机制、治疗靶点研究与新药研发；

3.   合理用药的临床-实验室综合评价研究。

论文与著作

1.代表性SCI论著

[1]     Yasmeen S, Liao X, Khan F U, Ihsan A U, LiX, Li C, Chen D, Yu F, Wang Z, Sembatya K R, Mikrani R, Zhou X. A novelapproach to devise the therapy for ventricular fibrillation by epicardialdelivery of lidocaine using active hydraulic ventricular attaching supportsystem: An experimental study in rats [J]. Journal of Biomedical Materials ResearchPart B: Applied Biomaterials, 2019, 107(5):1722-1731.

[2]     Wazir J, Ullah R, Li S, Hossain M A, Diallo M T, Khan F U, IhsanA U, Zhou X. Efficacy of acupuncture in the treatment of chronicprostatitis-chronic pelvic pain syndrome: a review of the literature [J]. IntUrol Nephrol, 2019,

[3]     Wang W, Naveed M, Majeed F, Cui X, Ihsan A U, Liu Z, Zubair H M,Tang M, Sohail M, Xiaohui Z. Morphological reseach on expression ofinflammatory mediators in murine models of chronic prostatitis/chronic pelvicpain syndrome (CP/CPPS) induced by T2 antigen [J]. Andrologia, 2019,51(11):e13435.

[4]     Tang M, Ullah R, Wazir J, Khan F U, Ihsan A U, Cui X, Wang W, HuM, Liu Y, Zhou X. Effect of Oral T2 Antigen on Chronic Prostatitis/ChronicPelvic Pain Syndrome in Mice Model [J]. Inflammation, 2019,

[5]     Mikrani R, Liang C, Naveed M, Kamboh A A, Abbas M, Chaurasiya B,Xue L, Xiaohui Z. A cardiac troponin I study in a minimally invasive myocardialinfarction canine model [J]. Journal of Applied Biomedicine,2019, 17(1):39-39.

[6]     Liu Y, Mikrani R, Xie D, Wazir J, Shrestha S, Ullah R, Baig M,Ahmed A, Srivastava P K, Thapa K B, Zhou X. Chronic prostatitis/chronic pelvicpain syndrome and prostate cancer: study of immune cells and cytokines [J]. FundamClin Pharmacol, 2019,

[7]     Li X, Mikrani R, Li C, Naveed M, Liu Z, Abbas M, Cheng Y, Han L,Wang Z, Zhou X. An epicardial delivery of nitroglycerine by active hydraulicventricular support drug delivery system improves cardiac function in a ratmodel [J]. Drug Deliv Transl Res, 2019,

[8]     Hu M, Wazir J, Ullah R, Wang W, Cui X, Tang M, Zhou X.Phytotherapy and physical therapy in the management of chronicprostatitis-chronic pelvic pain syndrome [J]. Int Urol Nephrol, 2019,51(7):1081-1088.

[9]     F. U. Khan N W, A. U. Ihsan, P. Khongorzul1, J. Wazir, W. Gang,Y. Mengqi, L. Xiaoqian, L. Han and Zhou Xiaohui. Analysis of the QualitiesMatching New Classification of Clinical Pharmacist [J]. Indian Journal of PharmaceuticalSciences, 2019, 81(1):2-10.

[10]  Cheng Y, Cao Y, Ihsan A U, Khan F U, Li X, Xie D, Cui X, Wang W,Liu Z, Li C, Ahmad K A, Sembatya K R, Mikrani R, Zhou X. Novel Treatment ofExperimental Autoimmune Prostatitis by Nanoparticle-Conjugated AutoantigenPeptide T2 [J]. Inflammation, 2019, 42(3):1071-1081.

[11]  Cao Y, Cheng Y, Ihsan A U, Khan F U, Xie D, Cui X, Wang W, Zhou X.A nanoparticle-coupled T2 peptide induces immune tolerance and ameliorateschronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model [J]. Fundamental& Clinical Pharmacology, 2019, 33(3):267-276.

[12]  Zhang L, Ihsan A U, Cao Y, Cheng Y, Zhou X. Establishment ofexperimental autoimmune prostatitis model by T2 peptide in aluminium hydroxideadjuvant [J]. Andrologia, 2018, 50(3):

[13]  Yue S, Naveed M, Gang W, Chen D, Wang Z, Yu F, Zhou X. Cardiacsupport device (ASD) delivers bone marrow stem cells repetitively to epicardiumhas promising curative effects in advanced heart failure [J]. BiomedicalMicrodevices, 2018, 20(2):40.

[14]  Wang W, Naveed M, Baig M, Abbas M, Xiaohui Z. Experimental rodentmodels of chronic prostatitis and evaluation criteria [J]. Biomed Pharmacother,2018, 108(1894-1901.

[15]  Naveed M, Mohammad I S, Xue L, Khan S, Gang W, Cao Y, Cheng Y, CuiX, DingDing C, Feng Y, Zhijie W, Xiaohui Z. The promising future of ventricularrestraint therapy for the management of end-stage heart failure [J]. BiomedPharmacother, 2018, 99(25-32.

[16]  Naveed M, Han L, Khan G J, Yasmeen S, Mikrani R, Abbas M, Cunyu L,Xiaohui Z. Cardio-supportive devices (VRD & DCC device) and patches foradvanced heart failure: A review, summary of state of the art and futuredirections [J]. Biomed Pharmacother, 2018, 102(41-54.

[17]  Naveed M, Han L, Hasnat M, Baig M, Wang W, Mikrani R, Zhiwei L,Sembatya K R, Xie D, Zhou X. Suppression of TGP on myocardial remodeling byregulating the NF-kappaB pathway [J]. Biomed Pharmacother, 2018,108(1460-1468.

[18]  Naveed M, BiBi J, Kamboh A A, Suheryani I, Kakar I, Fazlani S A,FangFang X, Kalhoro S A, Yunjuan L, Kakar M U, Abd El-Hack M E, Noreldin A E,Zhixiang S, LiXia C, XiaoHui Z. Pharmacological values and therapeuticproperties of black tea (Camellia sinensis): A comprehensive overview [J]. BiomedPharmacother, 2018, 100(521-531.

[19]  Ihsan A U, Khan F U, Khongorzul P, Ahmad K A, Naveed M, Yasmeen S,Cao Y, Taleb A, Maiti R, Akhter F, Liao X, Li X, Cheng Y, Khan H U, Alam K,Zhou X. Role of oxidative stress in pathology of chronic prostatitis/chronicpelvic pain syndrome and male infertility and antioxidants function inameliorating oxidative stress [J]. Biomed Pharmacother, 2018,106(714-723.

[20]  Zhang L, Ihsan A U, Cao Y, Khan F U, Cheng Y, Han L, Zhou X. AnImmunogenic Peptide, T2 Induces Interstitial Cystitis/Painful Bladder Syndrome:an Autoimmune Mouse Model for Interstitial Cystitis/Painful Bladder Syndrome[J]. Inflammation,2017, 40(6):2033-2041.

[21]  Nawaz W, Khan F U, Khan M Z, Gang W, Yang M, Liao X, Zhang L, IhsanA U, Khan A, Han L, Zhou X. Exo-organoplasty interventions: A brief review ofpast, present and future directions for advance heart failure management [J]. BiomedPharmacother, 2017, 88(162-172.

[22]  Naveed M, Wenhua L, Gang W, Mohammad I S, Abbas M, Liao X, Yang M,Zhang L, Liu X, Qi X, Chen Y, Jiadi L, Ye L, Zhijie W, Ding C D, Feng Y,Xiaohui Z. A novel ventricular restraint device (ASD) repetitively deliverSalvia miltiorrhiza to epicardium have good curative effects in heart failuremanagement [J]. Biomed Pharmacother, 2017, 95(701-710.

[23]  Naveed M, Hejazi V, Abbas M, Kamboh A A, Khan G J, Shumzaid M,Ahmad F, Babazadeh D, FangFang X, Modarresi-Ghazani F, WenHua L, XiaoHui Z.Chlorogenic acid (CGA): A pharmacological review and call for further research[J]. BiomedPharmacother, 2017, 97(67-74.

[24]  Khan F U, Ihsan A U, Nawaz W, Khan M Z, Yang M, Wang G, Liao X, HanL, Zhou X. A novel mouse model of chronic prostatitis/chronic pelvic painsyndrome induced by immunization of special peptide fragment with aluminumhydroxide adjuvant [J]. Immunol Lett, 2017, 187(61-67.

[25]  Khan F U, Ihsan A U, Khan H U, Jana R, Wazir J, Khongorzul P, WaqarM, Zhou X. Comprehensive overview of prostatitis [J]. Biomed Pharmacother,2017, 94(1064-1076.

[26]  Ihsan A U, Khan F U, Nawaz W, Khan M Z, Yang M, Zhou X.Establishment of a rat model of chronic Prostatitis/Chronic Pelvic PainSyndrome (CP/CPPS) induced by immunization with a novel peptide T2 [J]. BiomedPharmacother, 2017, 91(687-692.

[27]  Yang M Q, Ye L L, Liu X L, Qi X M, Lv J D, Wang G, Farhan U K,Waqas N, Chen D D, Han L, Zhou X H. Gingerol activates noxious cold ion channelTRPA1 in gastrointestinal tract [J]. Chin J Nat Med, 2016, 14(6):434-440.

[28]  Qi X, Han L, Liu X, Zhi J, Zhao B, Chen D, Yu F, Zhou X. Prostateextract with aluminum hydroxide injection as a novel animal model for chronicprostatitis/chronic pelvic pain syndrome [J]. Urology, 2012, 80(6):1389e1389-1315.

[29]  Zhou X H, Li L D, Wu L M, Wang W, Han L, Yang J, Qiao H X, Zhou XF. A minimally invasive model of myocardial infarction made by video-assistedthoracoscopic surgery [J]. Methods Find Exp Clin Pharmacol,2007, 29(4):283-290.

[30]  Zhou X H, Li L D, Wu L M, Han L, Liu Z D, Yang J X, Lv Y W, You CL, Zhou Z H. Increased inflammatory factors activity in model rats withexperimental autoimmune prostatitis [J]. Arch Androl, 2007, 53(2):49-52.

[31]  Zhou X H, Han L, Wang W, Li L D, Wu L M, Qiao H X, Yang J, Zhou XF. Subacute bloodstream blockade effect by supercontraction of spider silk [J].MethodsFind Exp Clin Pharmacol, 2006, 28(10):713-717.

2.教材编写

[1]《临床药理学》. 主编. 南京: 江苏凤凰科学技术出版社, 2018年.

[2]《临床药物治疗学（案例版，第2版）》（全国高等医药院校规划教材）.北京:科学出版社，2017年；

[3]《临床医学概论（第2版）》（全国高等学校药学类专业第八轮规划教材）.北京:人民卫生出版社，2016年；

[4]《临床药物治疗学（第4版）》（药学类专业用全国高等学校教材）.北京:人民卫生出版社，2016年；

[5]《临床中药学（第1版）》（中药学专业用全国高等学校教材）.北京:人民卫生出版社，2012年；

[6]《临床药物治疗学（第3版）》（药学类专业用全国高等学校教材）.北京:人民卫生出版社，2011年；

[7]《临床药物治疗学（案例版，第1版）》（全国高等医药院校规划教材）.北京:科学出版社，2009年。